Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on: December 25,2023

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i

Updated on:December 25,2023

Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainMicrovascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to

Updated on: April 30,2024

Black men found to have greater microvascular dysfunction than white men after prostate cancer diagnosis

byAmerican Physiological SocietyCredit: Pixabay/CC0 Public DomainMicrovascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to

Updated on:April 30,2024

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on: May 06,2024

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on:May 06,2024

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

Updated on: December 28,2023

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

Updated on:December 28,2023

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on: January 10,2024

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on:January 10,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on: April 09,2024

CAR-T cell researchers optimistic about future of treating blood cancers

by Kelley Luckstein,Mayo ClinicCredit: AI-generated imageSurvival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some bl

Updated on:April 09,2024

Cancer during young adulthood carries long-term mental toll, study finds

Updated on: June 14,2025

Cancer during young adulthood carries long-term mental toll, study finds

Updated on:June 14,2025

Immunotherapy for HPV+ head and neck cancer: Awakening the force within

by Emory UniversityCredit: Pixabay/CC0 Public DomainA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the

Updated on: April 16,2024

Immunotherapy for HPV+ head and neck cancer: Awakening the force within

by Emory UniversityCredit: Pixabay/CC0 Public DomainA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the

Updated on:April 16,2024

Novel blood test helps improve cancer treatments

by Kurt Bodenmüller,University of ZurichStudy scheme depicting the plasma sample collection schedule in the different patient groups. Credit:Radiotherapy and Oncology(2024). DOI: 10.

Updated on: July 08,2024

Novel blood test helps improve cancer treatments

by Kurt Bodenmüller,University of ZurichStudy scheme depicting the plasma sample collection schedule in the different patient groups. Credit:Radiotherapy and Oncology(2024). DOI: 10.

Updated on:July 08,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on: June 17,2024

Building trust and saving lives: A community approach to genetic education

by Medical University of South CarolinaCatilin Allen, Ph.D., of MUSC Hollings Cancer Center. Credit: Medical University of South Carolina, Sarah Pack.Changes to DNA, known as mutations, can incre

Updated on:June 17,2024

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on: December 28,2023

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on:December 28,2023

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024